Published in J Immunol on May 01, 2005
Adipokines in inflammation and metabolic disease. Nat Rev Immunol (2011) 8.92
Adipokines and insulin resistance. Mol Med (2008) 2.97
Alternatively activated macrophage-derived RELM-{alpha} is a negative regulator of type 2 inflammation in the lung. J Exp Med (2009) 2.51
Adipose tissue: the new endocrine organ? A review article. Dig Dis Sci (2008) 2.26
Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis (2006) 2.25
Molecular signatures of obstructive sleep apnea in adults: a review and perspective. Sleep (2009) 1.76
Metabolic syndrome meets osteoarthritis. Nat Rev Rheumatol (2012) 1.75
Absence of bacterially induced RELMbeta reduces injury in the dextran sodium sulfate model of colitis. J Clin Invest (2006) 1.66
Adipokines mediate inflammation and insulin resistance. Front Endocrinol (Lausanne) (2013) 1.62
Obesity and osteoarthritis: more complex than predicted! Ann Rheum Dis (2006) 1.59
Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN Inflamm (2013) 1.59
Plasma resistin levels associate with risk for hypertension among nondiabetic women. J Am Soc Nephrol (2010) 1.54
Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. Arthritis Rheum (2009) 1.45
Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. Annu Rev Nutr (2010) 1.44
Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum. Ann Rheum Dis (2006) 1.40
Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes. PLoS One (2006) 1.38
Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander? Gut (2006) 1.34
Resistin-like molecule alpha enhances myeloid cell activation and promotes colitis. J Allergy Clin Immunol (2008) 1.32
Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis. Arthritis Rheum (2009) 1.30
Resistin competes with lipopolysaccharide for binding to toll-like receptor 4. J Cell Mol Med (2009) 1.29
Adipokines in nonalcoholic steatohepatitis: from pathogenesis to implications in diagnosis and therapy. Mediators Inflamm (2009) 1.26
Resistin as an intrahepatic cytokine: overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells. Am J Pathol (2006) 1.14
Aromatase inhibitors, estrogens and musculoskeletal pain: estrogen-dependent T-cell leukemia 1A (TCL1A) gene-mediated regulation of cytokine expression. Breast Cancer Res (2012) 1.13
Hypothalamic resistin induces hepatic insulin resistance. J Clin Invest (2007) 1.10
The role of adipokines in connective tissue diseases. Eur J Nutr (2012) 1.09
Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation. Br J Dermatol (2008) 1.08
Association of circulating adiponectin levels with progression of radiographic joint destruction in rheumatoid arthritis. Ann Rheum Dis (2011) 1.08
New serological biomarkers of inflammatory bowel disease. World J Gastroenterol (2008) 1.06
Adenylyl cyclase-associated protein 1 is a receptor for human resistin and mediates inflammatory actions of human monocytes. Cell Metab (2014) 1.06
Geranylgeranyltransferase type I (GGTase-I) deficiency hyperactivates macrophages and induces erosive arthritis in mice. J Clin Invest (2011) 1.05
Neuroendocrine factors in the regulation of inflammation: excessive adiposity and calorie restriction. Exp Gerontol (2008) 1.05
Sarcopenia, obesity, and natural killer cell immune senescence in aging: altered cytokine levels as a common mechanism. Aging (Albany NY) (2012) 1.05
Resistin induces expression of proinflammatory cytokines and chemokines in human articular chondrocytes via transcription and messenger RNA stabilization. Arthritis Rheum (2010) 1.04
Resistin in rodents and humans. Diabetes Metab J (2013) 1.03
Idiopathic inflammatory myopathies: pathogenic mechanisms of muscle weakness. Skelet Muscle (2013) 1.03
New role of resistin in lipopolysaccharide-induced liver damage in mice. J Pharmacol Exp Ther (2008) 1.02
Circulating levels of resistin and risk of type 2 diabetes in men and women: results from two prospective cohorts. Diabetes Care (2008) 1.01
Central resistin overexposure induces insulin resistance through Toll-like receptor 4. Diabetes (2012) 1.01
The effects of adipokines on cartilage and meniscus catabolism. Connect Tissue Res (2011) 1.01
Resistin in amniotic fluid and its association with intra-amniotic infection and inflammation. J Matern Fetal Neonatal Med (2008) 0.97
Resistin is associated with biomarkers of inflammation while total and high-molecular weight adiponectin are associated with biomarkers of inflammation, insulin resistance, and endothelial function. Eur J Endocrinol (2009) 0.97
Understanding Haemophilus parasuis infection in porcine spleen through a transcriptomics approach. BMC Genomics (2009) 0.96
Serum levels of adipokines resistin and leptin in patients with colon cancer. J Med Life (2011) 0.96
Diabetes and hypertension markedly increased the risk of ischemic stroke associated with high serum resistin concentration in a general Japanese population: the Hisayama Study. Cardiovasc Diabetol (2009) 0.96
Resistin and interleukin-6 exhibit racially-disparate expression in breast cancer patients, display molecular association and promote growth and aggressiveness of tumor cells through STAT3 activation. Oncotarget (2015) 0.96
Resistin-like molecule α promotes pathogenic Th17 cell responses and bacterial-induced intestinal inflammation. J Immunol (2013) 0.96
Long-term in vivo resistin overexpression induces myocardial dysfunction and remodeling in rats. J Mol Cell Cardiol (2011) 0.95
Peripheral blood mononuclear cells: a potential source of homeostatic imbalance markers associated with obesity development. Pflugers Arch (2013) 0.95
Role of adipokines in atherosclerosis: interferences with cardiovascular complications in rheumatic diseases. Mediators Inflamm (2012) 0.95
Adipokines in psoriatic arthritis patients: the correlations with osteoclast precursors and bone erosions. PLoS One (2012) 0.95
Composition of dietary fat source shapes gut microbiota architecture and alters host inflammatory mediators in mouse adipose tissue. JPEN J Parenter Enteral Nutr (2013) 0.95
Adipokines, metabolic syndrome and rheumatic diseases. J Immunol Res (2014) 0.95
Association between obesity-related adipokines and colorectal cancer: a case-control study and meta-analysis. World J Gastroenterol (2014) 0.94
Clinical implications of adipocytokines and newly emerging metabolic factors with relation to insulin resistance and cardiovascular health. Front Endocrinol (Lausanne) (2013) 0.94
Central obesity, type 2 diabetes and insulin: exploring a pathway full of thorns. Arch Med Sci (2015) 0.93
Value of adipokines in predicting the severity of acute pancreatitis: comprehensive review. World J Gastroenterol (2012) 0.92
Retinol binding protein 4: an adipokine associated with intra-amniotic infection/inflammation. J Matern Fetal Neonatal Med (2010) 0.91
Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease. Circ Res (2016) 0.91
The role of adipocytokines in the pathogenesis of knee joint osteoarthritis. Int Orthop (2015) 0.91
Increased plasma levels of adipokines and inflammatory markers in older women with persistent HPV infection. Cytokine (2010) 0.90
Inflammatory induction of human resistin causes insulin resistance in endotoxemic mice. Diabetes (2011) 0.90
Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells. Mediators Inflamm (2010) 0.90
Response of swine spleen to Streptococcus suis infection revealed by transcription analysis. BMC Genomics (2010) 0.90
Peripheral mononuclear cell resistin mRNA expression is increased in type 2 diabetic women. Mediators Inflamm (2008) 0.89
Human resistin promotes neutrophil proinflammatory activation and neutrophil extracellular trap formation and increases severity of acute lung injury. J Immunol (2014) 0.89
Deregulation of adipokines related to target organ damage on resistant hypertension. J Hum Hypertens (2013) 0.88
Changes in peroxisome proliferator-activated receptor-gamma activity in children with septic shock. Intensive Care Med (2009) 0.88
Adipokines and insulin action: A sensitive issue. Adipocyte (2014) 0.88
A short-term diet and exercise intervention ameliorates inflammation and markers of metabolic health in overweight/obese children. Am J Physiol Endocrinol Metab (2012) 0.88
Treatment-specific changes in circulating adipocytokines: a comparison between tumour necrosis factor blockade and glucocorticoid treatment for rheumatoid arthritis. Ann Rheum Dis (2012) 0.88
Beyond fat mass: exploring the role of adipokines in rheumatic diseases. ScientificWorldJournal (2011) 0.87
Retinol binding protein 4--a novel association with early-onset preeclampsia. J Perinat Med (2010) 0.87
The association of plasma resistin with dietary sodium manipulation, the renin-angiotensin-aldosterone system, and 25-hydroxyvitamin D3 in human hypertension. Clin Endocrinol (Oxf) (2011) 0.87
Role of adipokines and peroxisome proliferator-activated receptors in nonalcoholic fatty liver disease. World J Hepatol (2014) 0.87
Role of adipokines signaling in the modulation of T cells function. Front Immunol (2013) 0.87
The pathophysiology of obesity and its clinical manifestations. Gastroenterol Hepatol (N Y) (2007) 0.87
Immunological contributions to adipose tissue homeostasis. Semin Immunol (2015) 0.86
Resistin up-regulates COX-2 expression via TAK1-IKK-NF-kappaB signaling pathway. Inflammation (2010) 0.86
Resistin in idiopathic inflammatory myopathies. Arthritis Res Ther (2012) 0.86
Secret talk between adipose tissue and central nervous system via secreted factors-an emerging frontier in the neurodegenerative research. J Neuroinflammation (2016) 0.86
Osteoarthritis: genes, nature-nurture interaction and the role of leptin. Int Orthop (2013) 0.85
Role of resistin as a marker of inflammation in systemic lupus erythematosus. Arthritis Res Ther (2008) 0.85
Inflammation and oxidative stress in obesity-related glomerulopathy. Int J Nephrol (2012) 0.85
Mechanism of inhibitory effect of atorvastatin on resistin expression induced by tumor necrosis factor-alpha in macrophages. J Biomed Sci (2009) 0.85
The relationship between hepatic resistin overexpression and inflammation in patients with nonalcoholic steatohepatitis. BMC Gastroenterol (2014) 0.84
Correlates of resistin in children with chronic kidney disease: the chronic kidney disease in children cohort. J Pediatr (2012) 0.84
Pharmacogenomics of endocrine therapy in breast cancer. J Hum Genet (2013) 0.84
Resistin in inflammatory and degenerative rheumatologic diseases. Relationship between resistin and rheumatoid arthritis disease progression. Z Rheumatol (2013) 0.83
Adipokines in bone disease. Nat Rev Rheumatol (2016) 0.83
Gene expression profiling in the lungs of pigs with different susceptibilities to Glässer's disease. BMC Genomics (2010) 0.83
Dysregulation of maternal serum adiponectin in preterm labor. J Matern Fetal Neonatal Med (2009) 0.83
Obesity aggravates the joint inflammation in a collagen-induced arthritis model through deviation to Th17 differentiation. Exp Mol Med (2012) 0.83
Resistin in serum and gingival crevicular fluid as a marker of periodontal inflammation and its correlation with single-nucleotide polymorphism in human resistin gene at -420. Contemp Clin Dent (2013) 0.82
Running a marathon induces changes in adipokine levels and in markers of cartilage degradation--novel role for resistin. PLoS One (2014) 0.82
High insulin and leptin increase resistin and inflammatory cytokine production from human mononuclear cells. Biomed Res Int (2012) 0.82
Serum adiponectin and resistin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome. Ther Adv Endocrinol Metab (2011) 0.81
The serum levels of resistin in ankylosing spondylitis patients: a pilot study. Rheumatol Int (2010) 0.81
Transcription of human resistin gene involves an interaction of Sp1 with peroxisome proliferator-activating receptor gamma (PPARgamma). PLoS One (2010) 0.81
Resistin is associated with mortality in patients with traumatic brain injury. Crit Care (2010) 0.81
Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med (2006) 9.53
Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem (2003) 3.57
One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial. Diabetes Care (2009) 2.75
Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol (2007) 2.70
The Staphylococcus aureus surface protein IsdA mediates resistance to innate defenses of human skin. Cell Host Microbe (2007) 2.27
Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men. J Bone Miner Res (2009) 2.20
Positive effects of moderate exercise on glycosaminoglycan content in knee cartilage: a four-month, randomized, controlled trial in patients at risk of osteoarthritis. Arthritis Rheum (2005) 2.19
Endogenously oxidized mitochondrial DNA induces in vivo and in vitro inflammatory responses. J Leukoc Biol (2004) 2.17
Impaired preadipocyte differentiation in human abdominal obesity: role of Wnt, tumor necrosis factor-alpha, and inflammation. Diabetes (2009) 2.11
[Reply on new drugs against type 2 diabetes: important to gain experience and knowledge]. Lakartidningen (2008) 2.03
High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis. Arthritis Rheum (2003) 1.93
Catalase (KatA) and alkyl hydroperoxide reductase (AhpC) have compensatory roles in peroxide stress resistance and are required for survival, persistence, and nasal colonization in Staphylococcus aureus. J Bacteriol (2006) 1.86
Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. J Immunol (2004) 1.80
Cytokines promote Wnt signaling and inflammation and impair the normal differentiation and lipid accumulation in 3T3-L1 preadipocytes. J Biol Chem (2006) 1.70
Evidence of impaired adipogenesis in insulin resistance. Biochem Biophys Res Commun (2004) 1.65
Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement. Arthritis Rheum (2003) 1.65
Inflammation and impaired adipogenesis in hypertrophic obesity in man. Am J Physiol Endocrinol Metab (2009) 1.63
Reduced expression of FOXC2 and brown adipogenic genes in human subjects with insulin resistance. Obes Res (2003) 1.63
Retinol-binding protein 4 inhibits insulin signaling in adipocytes by inducing proinflammatory cytokines in macrophages through a c-Jun N-terminal kinase- and toll-like receptor 4-dependent and retinol-independent mechanism. Mol Cell Biol (2012) 1.59
Delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) in early knee osteoarthritis. Magn Reson Med (2003) 1.58
Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia. Neurobiol Aging (2002) 1.56
Effects of exenatide on measures of β-cell function after 3 years in metformin-treated patients with type 2 diabetes. Diabetes Care (2011) 1.53
Toward imaging biomarkers for osteoarthritis. Clin Orthop Relat Res (2004) 1.51
Complement deficiency ameliorates collagen-induced arthritis in mice. J Immunol (2002) 1.51
Macrophage-derived proinflammatory factors contribute to the development of arthritis and myositis after infection with an arthrogenic alphavirus. J Infect Dis (2008) 1.48
GGTase-I deficiency reduces tumor formation and improves survival in mice with K-RAS-induced lung cancer. J Clin Invest (2007) 1.47
Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control. Arthritis Res Ther (2005) 1.43
Sclerosing injections in midportion Achilles tendinopathy: a retrospective study of 25 patients. Knee Surg Sports Traumatol Arthrosc (2008) 1.40
Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes. PLoS One (2006) 1.38
Characterization of IsaA and SceD, two putative lytic transglycosylases of Staphylococcus aureus. J Bacteriol (2007) 1.34
Single-nucleotide polymorphism rs7754840 of CDKAL1 is associated with impaired insulin secretion in nondiabetic offspring of type 2 diabetic subjects and in a large sample of men with normal glucose tolerance. J Clin Endocrinol Metab (2008) 1.31
WISP2 regulates preadipocyte commitment and PPARγ activation by BMP4. Proc Natl Acad Sci U S A (2013) 1.30
Variant near ADAMTS9 known to associate with type 2 diabetes is related to insulin resistance in offspring of type 2 diabetes patients--EUGENE2 study. PLoS One (2009) 1.29
Plasma cells and Fc receptors in human adipose tissue--lipogenic and anti-inflammatory effects of immunoglobulins on adipocytes. Biochem Biophys Res Commun (2006) 1.29
Enhanced polyamine catabolism alters homeostatic control of white adipose tissue mass, energy expenditure, and glucose metabolism. Mol Cell Biol (2007) 1.28
A candidate type 2 diabetes polymorphism near the HHEX locus affects acute glucose-stimulated insulin release in European populations: results from the EUGENE2 study. Diabetes (2007) 1.27
Short- and long-term effects of anti-CD20 treatment on B cell ontogeny in bone marrow of patients with rheumatoid arthritis. Arthritis Res Ther (2009) 1.26
Mendelian randomization studies do not support a causal role for reduced circulating adiponectin levels in insulin resistance and type 2 diabetes. Diabetes (2013) 1.25
Soluble receptor for advanced glycation end products triggers a proinflammatory cytokine cascade via beta2 integrin Mac-1. Arthritis Rheum (2006) 1.24
Predictors of weight loss in adults with topiramate-treated epilepsy. Obes Res (2003) 1.24
Adiponectin gene activation by thiazolidinediones requires PPAR gamma 2, but not C/EBP alpha-evidence for differential regulation of the aP2 and adiponectin genes. Biochem Biophys Res Commun (2003) 1.21
Exenatide affects circulating cardiovascular risk biomarkers independently of changes in body composition. Diabetes Care (2010) 1.21
Linking diabetes and cancer: a consensus on complexity. Lancet (2010) 1.19
The Staphylococcus aureus response to unsaturated long chain free fatty acids: survival mechanisms and virulence implications. PLoS One (2009) 1.19
The uridine diphosphate glucuronosyltransferase 2B15 D85Y and 2B17 deletion polymorphisms predict the glucuronidation pattern of androgens and fat mass in men. J Clin Endocrinol Metab (2007) 1.19
Identification and characterization of sigma, a novel component of the Staphylococcus aureus stress and virulence responses. PLoS One (2008) 1.19
Ethanol prevents development of destructive arthritis. Proc Natl Acad Sci U S A (2006) 1.18
The dysregulated adipose tissue: a connecting link between insulin resistance, type 2 diabetes mellitus and atherosclerosis. Nutr Metab Cardiovasc Dis (2006) 1.17
Cartilage glycosaminoglycan loss in the acute phase after an anterior cruciate ligament injury: delayed gadolinium-enhanced magnetic resonance imaging of cartilage and synovial fluid analysis. Arthritis Rheum (2005) 1.17
Genetic predisposition for Type 2 diabetes, but not for overweight/obesity, is associated with a restricted adipogenesis. PLoS One (2011) 1.16
Cleavage of fibromodulin in cartilage explants involves removal of the N-terminal tyrosine sulfate-rich region by proteolysis at a site that is sensitive to matrix metalloproteinase-13. J Biol Chem (2003) 1.15
Fibrinogen binding sites P336 and Y338 of clumping factor A are crucial for Staphylococcus aureus virulence. PLoS One (2008) 1.14
Proteolysis of the collagen fibril in osteoarthritis. Biochem Soc Symp (2003) 1.14
A novel cellular marker of insulin resistance and early atherosclerosis in humans is related to impaired fat cell differentiation and low adiponectin. FASEB J (2003) 1.14
A standardized vascular disease health check in europe: a cost-effectiveness analysis. PLoS One (2013) 1.14
Activity level and subjective knee function 15 years after anterior cruciate ligament injury: a prospective, longitudinal study of nonreconstructed patients. Am J Sports Med (2007) 1.12
The WNT inhibitor Dickkopf 1 and bone morphogenetic protein 4 rescue adipogenesis in hypertrophic obesity in humans. Diabetes (2012) 1.11
Increased MAPK activation and impaired insulin signaling in subcutaneous microvascular endothelial cells in type 2 diabetes: the role of endothelin-1. Diabetes (2009) 1.11
Visfatin is an adipokine, but it is not regulated by thiazolidinediones. J Clin Endocrinol Metab (2006) 1.10
Inflamed adipose tissue, insulin resistance and vascular injury. Diabetes Metab Res Rev (2008) 1.10
Muscle strength, functional performance, and self-reported outcomes four years after arthroscopic partial meniscectomy in middle-aged patients. Arthritis Rheum (2006) 1.09
High local concentrations and effects on differentiation implicate interleukin-6 as a paracrine regulator. Obes Res (2004) 1.09
Critical role of signaling through IL-1 receptor for development of arthritis and sepsis during Staphylococcus aureus infection. J Immunol (2002) 1.09
Staphylococcus aureus: Staphylokinase. Int J Biochem Cell Biol (2005) 1.08
Decreased levels of the gelsolin plasma isoform in patients with rheumatoid arthritis. Arthritis Res Ther (2008) 1.08
Activation of canonical wingless-type MMTV integration site family (Wnt) signaling in mature adipocytes increases beta-catenin levels and leads to cell dedifferentiation and insulin resistance. J Biol Chem (2010) 1.08
One-year treatment with exenatide vs. insulin glargine: effects on postprandial glycemia, lipid profiles, and oxidative stress. Atherosclerosis (2010) 1.07
Genetic variants associated with glycine metabolism and their role in insulin sensitivity and type 2 diabetes. Diabetes (2013) 1.06
Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus. J Rheumatol (2008) 1.05
Balance between survivin, a key member of the apoptosis inhibitor family, and its specific antibodies determines erosivity in rheumatoid arthritis. Arthritis Res Ther (2005) 1.05
Inactivation of traP has no effect on the agr quorum-sensing system or virulence of Staphylococcus aureus. Infect Immun (2007) 1.04
Restricted adipogenesis in hypertrophic obesity: the role of WISP2, WNT, and BMP4. Diabetes (2013) 1.04
dGEMRIC (delayed gadolinium-enhanced MRI of cartilage) indicates adaptive capacity of human knee cartilage. Magn Reson Med (2004) 1.04
Tissue factor as a proinflammatory agent. Arthritis Res (2002) 1.04
Immune evasion by Staphylococcus aureus conferred by iron-regulated surface determinant protein IsdH. Microbiology (2009) 1.02
Phenotypic and functional characterization of human CD25+ B cells. Immunology (2006) 1.02
Arthritogenic properties of double-stranded (viral) RNA. J Immunol (2004) 1.01
Identification of the UBP1 locus as a critical blood pressure determinant using a combination of mouse and human genetics. PLoS Genet (2009) 1.00
Identification of an intracellular M17 family leucine aminopeptidase that is required for virulence in Staphylococcus aureus. Microbes Infect (2012) 0.99
Fatal outcome of bacteraemic patients caused by infection with staphylokinase-deficient Staphylococcus aureus strains. J Med Microbiol (2003) 0.99
The size of large adipose cells is a predictor of insulin resistance in first-degree relatives of type 2 diabetic patients. Obesity (Silver Spring) (2012) 0.97
Wnt-signaling is maintained and adipogenesis inhibited by TNFalpha but not MCP-1 and resistin. Biochem Biophys Res Commun (2007) 0.97
Extracellular mitochondrial DNA and oxidatively damaged DNA in synovial fluid of patients with rheumatoid arthritis. Arthritis Res Ther (2003) 0.97
The Novel Secreted Adipokine WNT1-inducible Signaling Pathway Protein 2 (WISP2) Is a Mesenchymal Cell Activator of Canonical WNT. J Biol Chem (2014) 0.96
T-box transcription-factor-deficient mice display increased joint pathology and failure of infection control during staphylococcal arthritis. Microbes Infect (2004) 0.96
Resistin is stored in neutrophil granules being released upon challenge with inflammatory stimuli. Biochim Biophys Acta (2009) 0.95
Repeatability of T1-quantification in dGEMRIC for three different acquisition techniques: two-dimensional inversion recovery, three-dimensional look locker, and three-dimensional variable flip angle. J Magn Reson Imaging (2010) 0.94
Dichloroacetate alleviates development of collagen II-induced arthritis in female DBA/1 mice. Arthritis Res Ther (2009) 0.93
Obesity in orthopedic patients. Surg Obes Relat Dis (2009) 0.93
High serum adiponectin predicts incident fractures in elderly men: Osteoporotic fractures in men (MrOS) Sweden. J Bone Miner Res (2012) 0.92
Monocyte chemoattractant protein-1 in subcutaneous abdominal adipose tissue: characterization of interstitial concentration and regulation of gene expression by insulin. J Clin Endocrinol Metab (2007) 0.92
Intra-articular fms-like tyrosine kinase 3 ligand expression is a driving force in induction and progression of arthritis. PLoS One (2008) 0.92
The impact of Fcgamma receptors on Staphylococcus aureus infection. Microb Pathog (2002) 0.92
Smoking and nicotine exposure delay development of collagen-induced arthritis in mice. Arthritis Res Ther (2009) 0.91
Survivin is an essential mediator of arthritis interacting with urokinase signalling. J Cell Mol Med (2009) 0.91